Table 2.
Comparison of clinical characteristics between patients who did and those who did not undergo photocoagulation therapy
| Variable | PC (+) | PC (−) | p |
|---|---|---|---|
| n | 34 | 722 | |
| Gender (male/female) | 4/30 | 286/436 | <0.001* |
| Age at onset (years) | 8 (6–11) | 7 (4–10) | 0.33** |
| Median HbA1c during the observational period (%) | 10.5 (9.5–11.8) | 8.1 (7.6-9.0) | <0.0001** |
| Age in 2010 or 2011 (years) | 29 (26–31) | 27 (23–29) | |
| Duration of diabetes in 2010 or 2011 (years) | 21 (17–24) | 18 (15–21) | <0.001** |
| Median HbA1c in 2010 or 2011 (%) | 8.4 (7.7–9.6) | 7.4 (6.7–8.3) | <0.0001** |
Median (interquartile range)
PC photocoagulation therapy
** Comparison with participants using the Kruskal–Wallis test